DENTALCORP HOLDINGS LTD (DNTL.CA) Stock Fundamental Analysis
TSX:DNTL - Toronto Stock Exchange - CA24874B1085 - Common Stock - Currency: CAD
Taking everything into account, DNTL scores 4 out of 10 in our fundamental rating. DNTL was compared to 17 industry peers in the Health Care Providers & Services industry. DNTL may be in some trouble as it scores bad on both profitability and health. DNTL is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
DNTL had positive earnings in the past year.
In the past year DNTL had a positive cash flow from operations.
DNTL had negative earnings in each of the past 5 years.
Of the past 5 years DNTL 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.46%, DNTL is in line with its industry, outperforming 43.75% of the companies in the same industry.
Looking at the Return On Equity, with a value of -4.71%, DNTL is in line with its industry, outperforming 43.75% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.99%, DNTL is in line with its industry, outperforming 43.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.46% | ||
| ROE | -4.71% | ||
| ROIC | 0.99% |
ROA(3y)-2.92%
ROA(5y)-3.49%
ROE(3y)-5.49%
ROE(5y)-10.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 2.85%, DNTL is in line with its industry, outperforming 50.00% of the companies in the same industry.
With an excellent Gross Margin value of 48.81%, DNTL belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
DNTL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.85% | ||
| PM (TTM) | N/A | ||
| GM | 48.81% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-1.1%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DNTL is destroying value.
Compared to 1 year ago, DNTL has more shares outstanding
DNTL has a worse debt/assets ratio than last year.
2.2 Solvency
DNTL has an Altman-Z score of 0.77. This is a bad value and indicates that DNTL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.77, DNTL is doing worse than 62.50% of the companies in the same industry.
The Debt to FCF ratio of DNTL is 8.88, which is on the high side as it means it would take DNTL, 8.88 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DNTL (8.88) is comparable to the rest of the industry.
DNTL has a Debt/Equity ratio of 0.77. This is a neutral value indicating DNTL is somewhat dependend on debt financing.
DNTL's Debt to Equity ratio of 0.77 is in line compared to the rest of the industry. DNTL outperforms 56.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 8.88 | ||
| Altman-Z | 0.77 |
ROIC/WACC0.13
WACC7.63%
2.3 Liquidity
A Current Ratio of 1.19 indicates that DNTL should not have too much problems paying its short term obligations.
DNTL has a better Current ratio (1.19) than 81.25% of its industry peers.
A Quick Ratio of 0.98 indicates that DNTL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.98, DNTL is in line with its industry, outperforming 56.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
DNTL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.85%.
DNTL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.27%.
The Revenue has been growing by 18.87% on average over the past years. This is quite good.
EPS 1Y (TTM)3.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.73%
Revenue 1Y (TTM)8.27%
Revenue growth 3Y28.87%
Revenue growth 5Y18.87%
Sales Q2Q%11.43%
3.2 Future
Based on estimates for the next years, DNTL will show a very strong growth in Earnings Per Share. The EPS will grow by 42.44% on average per year.
DNTL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.79% yearly.
EPS Next Y86.61%
EPS Next 2Y58.59%
EPS Next 3Y42.44%
EPS Next 5YN/A
Revenue Next Year8.47%
Revenue Next 2Y9.43%
Revenue Next 3Y9.79%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DNTL is valuated quite expensively with a Price/Earnings ratio of 28.78.
81.25% of the companies in the same industry are more expensive than DNTL, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.62, DNTL is valued at the same level.
Based on the Price/Forward Earnings ratio of 14.04, the valuation of DNTL can be described as correct.
100.00% of the companies in the same industry are more expensive than DNTL, based on the Price/Forward Earnings ratio.
DNTL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.78 | ||
| Fwd PE | 14.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DNTL is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, DNTL is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.54 | ||
| EV/EBITDA | 11.11 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DNTL's earnings are expected to grow with 42.44% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y58.59%
EPS Next 3Y42.44%
5. Dividend
5.1 Amount
DNTL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:DNTL (2/21/2025, 7:00:00 PM)
7.77
-0.08 (-1.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners10.43%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.46B
Analysts84
Price Target12.33 (58.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-33.71%
Min EPS beat(2)-69.72%
Max EPS beat(2)2.3%
EPS beat(4)2
Avg EPS beat(4)-36.43%
Min EPS beat(4)-100%
Max EPS beat(4)21.7%
EPS beat(8)5
Avg EPS beat(8)14.87%
EPS beat(12)6
Avg EPS beat(12)-6.29%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.46%
Min Revenue beat(2)-0.97%
Max Revenue beat(2)0.06%
Revenue beat(4)1
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-2.91%
Max Revenue beat(4)0.06%
Revenue beat(8)2
Avg Revenue beat(8)-1.28%
Revenue beat(12)3
Avg Revenue beat(12)-1.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.2%
EPS NQ rev (1m)6.67%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)0.63%
EPS NY rev (3m)-15.49%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.78 | ||
| Fwd PE | 14.04 | ||
| P/S | 0.97 | ||
| P/FCF | 9.54 | ||
| P/OCF | 7.76 | ||
| P/B | 0.85 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.11 |
EPS(TTM)0.27
EY3.47%
EPS(NY)0.55
Fwd EY7.12%
FCF(TTM)0.81
FCFY10.49%
OCF(TTM)1
OCFY12.89%
SpS8.03
BVpS9.19
TBVpS-4.22
PEG (NY)0.33
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.46% | ||
| ROE | -4.71% | ||
| ROCE | 1.37% | ||
| ROIC | 0.99% | ||
| ROICexc | 1.01% | ||
| ROICexgc | 5.71% | ||
| OM | 2.85% | ||
| PM (TTM) | N/A | ||
| GM | 48.81% | ||
| FCFM | 10.15% |
ROA(3y)-2.92%
ROA(5y)-3.49%
ROE(3y)-5.49%
ROE(5y)-10.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-1.1%
F-Score5
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 8.88 | ||
| Debt/EBITDA | 5.38 | ||
| Cap/Depr | 17.23% | ||
| Cap/Sales | 2.33% | ||
| Interest Coverage | 0.48 | ||
| Cash Conversion | 76.15% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.77 |
F-Score5
WACC7.63%
ROIC/WACC0.13
Cap/Depr(3y)14.42%
Cap/Depr(5y)15.19%
Cap/Sales(3y)2.15%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.73%
EPS Next Y86.61%
EPS Next 2Y58.59%
EPS Next 3Y42.44%
EPS Next 5YN/A
Revenue 1Y (TTM)8.27%
Revenue growth 3Y28.87%
Revenue growth 5Y18.87%
Sales Q2Q%11.43%
Revenue Next Year8.47%
Revenue Next 2Y9.43%
Revenue Next 3Y9.79%
Revenue Next 5YN/A
EBIT growth 1Y459.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.24%
EBIT Next 3Y37.16%
EBIT Next 5YN/A
FCF growth 1Y21.58%
FCF growth 3YN/A
FCF growth 5Y55.58%
OCF growth 1Y21.43%
OCF growth 3YN/A
OCF growth 5Y35.05%